Clinical Trials Directory

Trials / Completed

CompletedNCT04279483

GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments

Geo Smoking Study and Neural and Geospatial Examination of Smokers' Exposure to Retail Environments

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
343 (actual)
Sponsor
Abramson Cancer Center at Penn Medicine · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to learn more about the relationships between the brain, behavior, and natural daily exposure to particular environments, including the places where smokers regularly spend time and specific retail outlets.

Detailed description

Individual participation in this study will take place over a period of approximately 2 months. During (approximately) 6 weeks of the active study period, the participant will be asked to share their geolocation information, complete either (a) 3 online sessions (for all participants in 850796) and an optional fMRI scan (for a subset of protocol 850796) or (b) 3 in-person visits (2 of which involve getting fMRI brain scans, for protocol 822815), and complete short surveys and repeated tasks (e.g., responding to Ecological Momentary Assessment \[EMA\], using study-provided funds to make small purchases from a specified retail environment) in the weeks between visits.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTobacco retailerAssigned to make a small (\~$3.00) purchase from a tobacco retail store(s) using a study-provided debit card during each retail environment visit
BEHAVIORALNon-tobacco retailerAssigned to make a small (\~$3.00) purchase from a store that does not sell tobacco (non-tobacco retailer) using a study-provided debit card during each retail environment visit.

Timeline

Start date
2019-12-17
Primary completion
2024-06-10
Completion
2024-06-10
First posted
2020-02-21
Last updated
2025-08-14
Results posted
2025-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04279483. Inclusion in this directory is not an endorsement.